Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Who Benefits From Zero Based Budgeting highlights common situations where this method shines, including clarity, control, and goal attainment.
18,389 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
As the partial government shutdown stretches into weeks, houston airport, with nearly 40% TSA absences, becomes a foc...
Startale Group has closed a $63 million Series A led by SBI Group and Sony Innovation Fund, accelerating its Strium L...
If you’ve got $5,000 to invest, these three AI-driven stock picks offer a balanced blend of growth potential and prac...
As Reynolds prepares to report its 2026 earnings, investors are weighing growth catalysts, margin resilience, and pot...
Netflix and Meta are trading lower from recent highs, but their risk profiles differ. This piece weighs which merit a...
Indonesian telecoms chief Vikram Sinha is leading Indosat into sovereign AI territory, threading local-language model...
SpaceX's IPO is on the horizon, but you can gain exposure today through a strategic backdoor. This article explains w...
Bernstein raises Delta Air Lines price target to $88, highlighting a fuel-insulation edge that could bolster margins ...
New risk signals emerge as the S&P 500 grows more concentrated. Top 10 names and chipmakers now drive most of the mar...
LiveBy and Repliers unveil a new integration that brings neighborhood, school, and demographic context to real estate...
A cooler April jobs report challenges early COLA forecasts for Social Security. Investors weigh retirement income ris...